Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart L Silverman

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|February 4, 2009
Impact of osteoporosis treatment adherence on fracture rates in North America and EuropeEthel S Siris, Peter L Selby, Kenneth G Saag, et al.
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2013
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetineStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impactStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Southern Medical Journal|April 18, 2009
Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonatesNeil Binkley, Mark G Martens, Stuart L Silverman, et al.
Journal of the American Medical Directors Association|June 4, 2023
Economic and Humanistic Burden Among Medicare-Aged Women With Fragility Fracture in the United StatesChristie Teigland, Zulkarnain Pulungan, Jill Schinkel, et al.
Journal of Bone and Mineral Metabolism|August 6, 2010
Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record dataJoanne LaFleur, Carrie McAdam-Marx, Stephen S Alder, et al.
Bone|March 23, 2011
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFTPhilip N Sambrook, Stuart L Silverman, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Incidence of atypical nontraumatic diaphyseal fractures of the femurRichard M Dell, Annette L Adams, Denise F Greene, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|February 4, 2009
Impact of osteoporosis treatment adherence on fracture rates in North America and EuropeEthel S Siris, Peter L Selby, Kenneth G Saag, et al.
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2013
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetineStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impactStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Southern Medical Journal|April 18, 2009
Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonatesNeil Binkley, Mark G Martens, Stuart L Silverman, et al.
Journal of the American Medical Directors Association|June 4, 2023
Economic and Humanistic Burden Among Medicare-Aged Women With Fragility Fracture in the United StatesChristie Teigland, Zulkarnain Pulungan, Jill Schinkel, et al.
Journal of Bone and Mineral Metabolism|August 6, 2010
Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record dataJoanne LaFleur, Carrie McAdam-Marx, Stephen S Alder, et al.
Bone|March 23, 2011
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFTPhilip N Sambrook, Stuart L Silverman, Jane A Cauley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Incidence of atypical nontraumatic diaphyseal fractures of the femurRichard M Dell, Annette L Adams, Denise F Greene, et al.
Pageof 9